![Madhavan Balachandran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Madhavan Balachandran
Director/Board Member at
UNIQURE N.V.
Net worth: 4 M $ as of 30/09/2026
Profile
Presently, Madhavan Balachandran occupies the position of Chief Operating Officer for Brentwood Press & Publishing Co. and Chief Operating Officer at Nutcracker Therapeutics, Inc. Mr. Balachandran is also on the board of 5 other companies. In the past Mr. Balachandran held the position of Chief Executive Officer & Director at ADRx, Inc., Executive Vice President of Amgen, Inc., Vice President-Engineering of Glaxo Wellcome, Inc., Principal at Battelle Memorial Institute and Vice President of Puerto Rico USA Citizenship Foundation. He received an MBA from East Carolina University, an undergraduate degree from Indian Institute of Technology Bombay and a graduate degree from State University of New York at Buffalo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/06/2026 | 69,458 ( 0.03% ) | 1 M $ | 30/09/2026 | |
STEVANATO GROUP SPA 0.13% | 31/12/2025 | 65,976 ( 0.13% ) | 1 M $ | 30/09/2026 |
UNIQURE N.V. 0.06% | 17/06/2026 | 43,254 ( 0.06% ) | 1 M $ | 30/09/2026 |
| 30/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Madhavan Balachandran active positions
| Companies | Position | Start |
|---|---|---|
| UNIQURE N.V. | Director/Board Member | 14/09/2017 |
| STEVANATO GROUP S.P.A. | Director/Board Member | 01/09/2018 |
| REPLIMUNE GROUP, INC. | Director/Board Member | 05/09/2024 |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Develops medicine for treatment of neurodegenerative diseases and neurotrauma | Director/Board Member | 01/06/2018 |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. BiotechnologyHealth Technology Provides end-to-end RNA therapeutics research and development services | Corporate Officer/Principal | 23/09/2020 |
Brentwood Press & Publishing Co.
 Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Publishes newspapers | Chief Operating Officer | 23/09/2020 |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Director/Board Member | - |
Former positions of Madhavan Balachandran
| Companies | Position | End |
|---|---|---|
| CATALENT, INC. | Director/Board Member | 25/01/2024 |
ADRx, Inc.
 ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Chief Executive Officer | 01/10/2020 |
| ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Education of Madhavan Balachandran
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization for science and technology research & development | Commercial Services |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Publishes newspapers | Consumer Services |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Puerto Rico USA Citizenship Foundation | |
Stevanato Group SpA
 Stevanato Group SpA Medical SpecialtiesHealth Technology Designs, manufacturers and supplies glass bottles and glass tube containers | Health Technology |
Indian Institute of Technology Bombay
 Indian Institute of Technology Bombay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Develops medicine for treatment of neurodegenerative diseases and neurotrauma | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. BiotechnologyHealth Technology Provides end-to-end RNA therapeutics research and development services | Health Technology |
ADRx, Inc.
ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Commercial Services |
- Stock Market
- Insiders
- Madhavan Balachandran
